Abera Bioscience AB (NGM:ABERA)

Abera Bioscience AB Statistics

Total Valuation

NGM:ABERA has a market cap or net worth of SEK 107.47 million. The enterprise value is 101.97 million.

Market Cap	107.47M
Enterprise Value	101.97M

Important Dates

The next estimated earnings date is Monday, August 18, 2025.

Earnings Date	Aug 18, 2025
Ex-Dividend Date	n/a

Share Statistics

NGM:ABERA has 15.35 million shares outstanding. The number of shares has increased by 5.58% in one year.

Current Share Class	15.35M
Shares Outstanding	15.35M
Shares Change (YoY)	+5.58%
Shares Change (QoQ)	-24.00%
Owned by Insiders (%)	6.04%
Owned by Institutions (%)	n/a
Float	14.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.74
PB Ratio	12.40
P/TBV Ratio	12.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-139.87
EV / Sales	6.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-79.47

Financial Position

The company has a current ratio of 2.94

Current Ratio	2.94
Quick Ratio	2.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-981.00

Financial Efficiency

Return on equity (ROE) is -8.13% and return on invested capital (ROIC) is -6.84%.

Return on Equity (ROE)	-8.13%
Return on Assets (ROA)	-5.25%
Return on Invested Capital (ROIC)	-6.84%
Return on Capital Employed (ROCE)	-11.32%
Revenue Per Employee	3.19M
Profits Per Employee	-145,800
Employee Count	5
Asset Turnover	1.36
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.43% in the last 52 weeks. The beta is 1.08, so NGM:ABERA's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+54.43%
50-Day Moving Average	7.74
200-Day Moving Average	5.37
Relative Strength Index (RSI)	45.22
Average Volume (20 Days)	8,209

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:ABERA had revenue of SEK 15.93 million and -729,000 in losses. Loss per share was -0.05.

Revenue	15.93M
Gross Profit	15.93M
Operating Income	-981,000
Pretax Income	-729,000
Net Income	-729,000
EBITDA	n/a
EBIT	-981,000
Loss Per Share	-0.05

Balance Sheet

The company has 5.50 million in cash and n/a in debt, giving a net cash position of 5.50 million or 0.36 per share.

Cash & Cash Equivalents	5.50M
Total Debt	n/a
Net Cash	5.50M
Net Cash Per Share	0.36
Equity (Book Value)	8.67M
Book Value Per Share	0.56
Working Capital	5.75M

Cash Flow

In the last 12 months, operating cash flow was -152,000 and capital expenditures -1.13 million, giving a free cash flow of -1.28 million.

Operating Cash Flow	-152,000
Capital Expenditures	-1.13M
Free Cash Flow	-1.28M
FCF Per Share	-0.08

Margins

Gross margin is 100.00%, with operating and profit margins of -6.16% and -4.58%.

Gross Margin	100.00%
Operating Margin	-6.16%
Pretax Margin	-4.58%
Profit Margin	-4.58%
EBITDA Margin	n/a
EBIT Margin	-6.16%
FCF Margin	n/a

Dividends & Yields

NGM:ABERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.58%
Shareholder Yield	n/a
Earnings Yield	-0.68%
FCF Yield	-1.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:ABERA has an Altman Z-Score of 7.87 and a Piotroski F-Score of 2.

Altman Z-Score	7.87
Piotroski F-Score	2